Literature DB >> 19931009

Image-guided stereotactic body radiotherapy for lung tumors using BodyLoc with tomotherapy: clinical implementation and set-up accuracy.

Jining Zhou1, Barry Uhl, Kelly Dewitt, Mark Young, Brian Taylor, Ding-Yu Fei, Yeh-Chi Lo.   

Abstract

We investigated the use of a BodyLoc immobilization and stereotactic localization device combined with TomoTherapy megavoltage CT (MVCT) in lung stereotactic body radiotherapy (SBRT) to reduce set-up uncertainty and treatment time. Eight patients treated with 3-5 fractions of SBRT were retrospectively analyzed. A BodyLoc localizer was used in both CT simulation for localization and the initial patient treatment set-up. Patients were immobilized with a vacuum cushion on the back and a thermoplastic body cast on the anterior body. Pretreatment MVCT from the TomoTherapy unit was fused with the planning kilovoltage CT (KVCT) before each fraction of treatment to determine interfractional set-up error. The comparison of two MVCTs during a fraction of treatment resulted in the intrafractional uncertainty of the treatment. A total of 224 target isocenter shifts were analyzed to assess these inter- and intrafractional tumor motions. We found that for interfractional shifts, the mean set-up errors and standard deviations were -1.1 +/- 2.8 mm, -2.5 +/- 8.7 mm, and 4.1 +/- 2.6 mm, for lateral, longitudinal, and vertical variation, respectively; the mean setup rotational variation was -0.3 +/- 0.7 degrees; and the maximum motion was 13.5 mm in the longitudinal direction. For intrafractional shifts, the mean set-up errors and standard deviations were -0.1 +/- 0.7 mm, -0.3 +/- 2.0 mm, and 0.5 +/- 1.1 mm for the lateral, longitudinal, and vertical shifts, respectively; the mean rotational variation was 0.1 +/- 0.2 degrees; and the maximum motion was 3.8 mm in the longitudinal direction. There was no correlation among patient characteristics, set-up uncertainties, and isocenter shifts, and the interfractional set-up uncertainties were larger than the intrafractional isocenter shift. The results of this study suggested that image-guided stereotactic body radiotherapy using the BodyLoc immobilization system with TomoTherapy can improve treatment accuracy. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19931009     DOI: 10.1016/j.meddos.2008.12.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  5 in total

1.  Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors.

Authors:  Meguru Watanabe; Hiroshi Onishi; Kengo Kuriyama; Takafumi Komiyama; Kan Marino; Masayuki Araya; Ryo Saito; Shinichi Aoki; Yoshiyasu Maehata; Rihito Tominaga; Jitsuhiko Oguri; Naoki Sano; Tsutomu Araki
Journal:  J Radiat Res       Date:  2013-02-14       Impact factor: 2.724

2.  Feasibility study of automated framework for estimating lung tumor locations for target-based patient positioning in stereotactic body radiotherapy.

Authors:  Satoshi Yoshidome; Hidetaka Arimura; Katsumasa Nakamura; Yoshiyuki Shioyama; Kazushige Atsumi; Yasuhiko Nakamura; Hideki Yoshikawa; Kei Nishikawa; Hideki Hirata
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

3.  Evaluation of initial setup errors of two immobilization devices for lung stereotactic body radiation therapy (SBRT).

Authors:  Yoshihiro Ueda; Teruki Teshima; Higinia Cárdenes; Indra J Das
Journal:  J Appl Clin Med Phys       Date:  2017-05-14       Impact factor: 2.102

4.  Assessment of setup uncertainties for various tumor sites when using daily CBCT for more than 2200 VMAT treatments.

Authors:  Young-Kee Oh; Jong-Geun Baek; Ok-Bae Kim; Jin-Hee Kim
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102

5.  Evaluation of techniques for slice sensitivity profile measurement and analysis.

Authors:  Travis C Greene; X John Rong
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.